Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.570
-0.130 (-4.81%)
At close: Oct 30, 2026, 4:00 PM EDT
2.580
+0.010 (0.39%)
After-hours: Oct 30, 2026, 7:18 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $34.72 million as of October 30, 2026. It is the 32,758th most valuable company in the world and the 4,853rd biggest in the United States. Its market cap has increased by 138.36% in one year.
Market Cap
34.72M
Enterprise Value
24.39M
1-Year Change
138.36%
Global Rank
Country Rank
#4,853 United States
Category
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $34.72M, a decrease of -6.45%. That is a compound annual growth rate of -0.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 34.72M | 193.43% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 38.33M |
| Veru Inc. | 37.34M |
| Adicet Bio | 36.81M |
| Pelthos Therapeutics | 35.99M |
| GridAI Technologies | 35.12M |
| Lite Strategy | 34.06M |
| NanoViricides | 33.95M |
| Aldeyra Therapeutics | 33.80M |